Market Scenario:
The intra-nasal route of drug administration is becoming popular due to its noninvasive nature thereby reducing pain and threat of infections and allows the patient to self-administer drugs without any help from anyone. Moreover recent research has also pointed its applications related to drug delivery to the brain. Bioavailability of a drug is defined as the proportion of a drug entering the systemic circulation as compared to the dosage. Nasal drug delivery eliminates drug destruction by HCL present in the stomach thereby increasing bioavailability which reduces the dosage of the drug. The reduction in dosage leads to proportional reduction in side effects. Growth of over the counter nasal drugs such as inhalers for common cold is also driving the market.
The market for nasal drug delivery is increasing at a good CAGR due to the above mentioned advantages of nasal drugs. Other market driving factors include ease of administration, growing efficacy of the route due to development of drugs which are absorbed easily from the nasal route and the development of advanced products such as metered dose pressurized containers which deliver a very precise dose.
The market’s constraints are irritation of the nasal route and the low dose of the drug that can be delivered as compared to other route of administration. Other constraints includes low awareness and concurrent low popularity of the route which reduces economies of scale in producing these delivery devices. The market for nasal drug delivery has oligopolistic characteristic due to a few dominant players. Thus the power of the sellers is high and there is a premium on most nasal drug delivery products.
Taking all factors into consideration, we expect the Middle East and Africa nasal drug delivery market to reach around $ 1.59 billion in 2022 growing at a CAGR of 8.1%; this market was worth $ 1 billion in 2015.
Study Objectives Middle East and Africa Nasal drug delivery Market:
To provide detail analysis of the market structure along with forecast for the next 6 years of various segments and sub-segments of the Middle East and Africa nasal drug delivery market. To provide insights about factors affecting the market growth.
To analyze the market based on various analyses which includes price analysis, supply chain analysis, Porters Five Force analysis etc. To provide past and estimated future revenue of the Middle East and Africa nasal drug delivery market’s segments and sub-segments. To provide country level analysis of the market with respect to the current market size and future growth prospect.
To provide country level analysis of the market for segments which includes by dosage form, by system, by delivery technologies, by therapeutic applications and other sub segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies and drawing a competitive landscape for the market.
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments globally.
Key Players for Middle East and Africa Nasal Drug Delivery Market
Some of the key players in this market are Novartis AG, Pfizer, Inc., Sanofi-Aventis, Merck & Co., Inc., AptarGroup Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Becton Dickson & Company and others.
Segments:
Middle East and Africa nasal drug delivery market has been segmented on the basis of dosage form which comprises of drops, sprays, powder, gels and ointments. On the basis of system, market is segmented into unit dose, multi-dose and metered dose. On the basis of delivery technologies; market is segmented into spray, nebulizers and other. On the basis of therapeutic applications; market is segmented into rhinitis, congestion, vaccinations and others.
Regional Analysis of Middle East and Africa Nasal drug delivery Market:
UAE is the largest market for nasal drug delivery in entire Middle East and Africa nasal drug delivery Market closely followed by Egypt. The rest of Africa’s market is growing at a very fast rate due to huge unmet medical needs and growing popularity of nasal route.
Browse for more details @ https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696
About US:
No comments:
Post a Comment